Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding.
This retrospective analysis evaluated 294 women with endometrial hyperplasia among 1,469 abnormal uterine bleeding patients, finding obesity and hypertension as risk factors and noting four cases progressed to endometrial carcinoma.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (9)
- Levonorgestrel-releasing intrauterine system versus oral progestogens for non-atypical endometrial hyperplasia: predictors for treatment failure 2023
- High Variability in Clinical and Histopathological Patterns of Abnormal Uterine Bleeding in Perimenopausal Women 2022
- Correlation of Morphological Findings of Endometrium With Concerned Hormone Levels in Patients With Abnormal Uterine Bleeding: A Narrative Review 2022
- Abnormal uterine bleeding: A study of its clinical spectrum and incidence of histopathological patterns of endometrium as a function of age with parity 2018
- Levonorgestrel-releasing intrauterine system for endometrial hyperplasia 2017
- Therapeutic Options for Management of Endometrial Hyperplasia: An Update 2015
- Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials 2015
- Clinical, histopathological and therapeutic considerations in non-neoplastic abnormal uterine bleeding in menopause transition. 2011
- Endometrium 2002
Source provenance
- openalex
- last seen: 2026-05-10T10:48:26.591360+00:00